In addition, deletion of IRP-1 induces pulmonary hypertension (PH) and polycythemia in mice through the stabilization of HIF-2α, which increases ET-1 expression in pulmonary endothelial cells, further contributing to disease progression [126]. Here, EPAS1 is linked to pulmonary arterial hypertension.